In 2006, Gilead scientists began work on a potential long-acting HIV medication. After more than a decade of preclinical development and clinical trials, we’ve now announced topline results from a study investigating its use for HIV prevention. Scientific Innovation We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditio
![Gilead Sciences, Inc.](https://cdn-ak-scissors.b.st-hatena.com/image/square/b719221639fe353291a298d9a542e0cdfe6ab9e1/height=288;version=1;width=512/https%3A%2F%2Fwww.gilead.com%2F-%2Fmedia%2Fgilead-corporate%2Fimages%2Fog%2Fgilead_logo.jpg)